ARCHIVES

NMP22 Assay More Effective Than Conventional Lab Test

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: New San Antonio Center Wins Core Grants; ASCO forming A Technology Assessment Committee

July 19, 1991

Biomarker May Predict Prostate Cancer Metastases

December 27, 2013

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

Major New Grant Programs Approved In Carcinogenesis, Chemoprevention

May 9, 1980

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995